[Treatment and prevention of osteoporosis in patients with decreased renal function].
Decreased renal function and osteoporosis are both frequent conditions in the general population. Most drugs for treating osteoporosis seem safe for patients with mildly decreased renal function (glomerular filtration rate [GFR] 60-90 ml/min). In patients with a moderately decreased GFR of 30-60 ml/min, there are very few studies with BMD as endpoint. Most drugs seem safe in terms of affecting renal function. The aim should be to control calcium and vitamin D metabolism in patients with severely decreased renal function (GFR<30 ml/min) or on dialysis.